Skip to main content
Livermore
Livermore
ZHEN

SG Americas Securities, LLC

SEC CIK
0001313360
Latest filing
Aug 7, 2026

FATE holding history

Fate Therapeutics Inc in every 13F filed by SG Americas Securities, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FATE overviewAll 13F holders of FATEFull Q2 2026 holdings

Shares (Q2 2026)
31,593
Value
$85.0K
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of FATE by SG Americas Securities, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202631,593$85.0K<0.1%−48,546−60.6%ReducedHolders
Q1 202680,139$96.0K<0.1%+41,226+105.9%AddedHolders
Q4 202538,913$38.0K<0.1%+24,013+161.2%AddedHolders
Q3 202514,900$19.0K<0.1%−37,702−71.7%ReducedHolders
Q2 202552,602$59.0K<0.1%+18,100+52.5%AddedHolders
Q1 202534,502$27.0K<0.1%−10,372−23.1%ReducedHolders
Q4 202444,874$74.0K<0.1%+10,511+30.6%AddedHolders
Q3 202434,363$120.0K<0.1%−2,009−5.5%ReducedHolders
Q2 202436,372$119.0K<0.1%−1,084−2.9%ReducedHolders
Q1 202437,456$275.0K<0.1%−53,097−58.6%ReducedHolders
Q4 202390,553$339.0K<0.1%+16,911+23.0%AddedHolders
Q3 202373,642$156.0K<0.1%+73,642NewHolders
Q2 20230$00.0%−11,000−100.0%Sold outHolders
Q1 202311,000$63.0K<0.1%+11,000NewHolders
Q3 20220$00.0%−13,076−100.0%Sold outHolders
Q2 202213,076$324.0K<0.1%−91,629−87.5%ReducedHolders
Q1 2022104,705$4.06M<0.1%−315,485−75.1%ReducedHolders
Q4 2021420,190$24.6M0.2%+363,576+642.2%AddedHolders
Q3 202156,614$3.36M<0.1%+3,543+6.7%AddedHolders
Q2 202153,071$4.61M<0.1%+35,372+199.9%AddedHolders
Q1 202117,699$1.46M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.